Peter Boström - UTU Research Portal

Peter Boström

- Professor,
Surgery (Department of Clinical Medicine)

peter.bostrom@utu.fi

: https://orcid.org/0000-0003-3647-0015

22 of 24

Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis (2015)
- Magnetic Resonance in Medicine
Jussi Toivonen, Harri Merisaari, Marko Pesola, Pekka Taimen, Peter J. Boström, Tapio Pahikkala, Hannu J. Aronen, Ivan Jambor
PSA ja eturauhassyövän verinäytediagnostiikka (2015)
- Duodecim
Seikkula H, Pettersson K, Boström PJ
Reply from authors re: Robert S. Svatek. Long-term outcomes of the FinnBladder-4 study. Eur Urol 2015;68:618-9: which type of maintenance matters? (2015)
- European Urology
Järvinen R, Kaasinen E, Marttila T, Rintala E, Boström P
Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer (2015)
- PLoS ONE
Boström MM, Irjala H, Mirtti T, Taimen P, Kauko T, Ålgars A, Jalkanen S, Boström PJ
Bulbourethral gland adenocarcinoma in a 25-year-old man without comorbidities – Radical resection of proximal urethrae with Mitrofanoff-type appendicovesicostomy (2014)
- Scandinavian Journal of Urology and Nephrology
Syvänen KT, Taimen P, Salminen A, Kuusisto K, Boström PJ
European Association of Urology (@Uroweb) – Recommendations on the Appropriate Use of Social Media (2014)
- European Urology
Morgan Rouprêt, Todd M. Morgan, Peter J. Bostrom, Matthew R. Cooperberg, Alexander Kutikov, Kate D. Linton, Joan Palou, Luis Martínez-Piñeiro, Henk van der Poel, Carl Wijburg, Andrew Winterbottom, Henry H. Woo, Manfred P. Wirth, James W.F. Catto
FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer (2014)
- Virchows Archiv
Yann Neuzillet, Bas W. G. van Rhijn, Nadia L. Prigoda, Bharati Bapat, Liyang Liu, Peter J. Bostrom, Neil E. Fleshner, Brenda L. Gallie, Alexandre R. Zlotta, Michael A. S. Jewett, Theo H. van der Kwast
Le Fibroblast Growth Factor Receptor 3 (FGFR3), cible thérapeutique pour le traitement personnalisé du cancer de la vessie : validation anatomo-pathologique du concept (2014)
- Progrès en Urologie
Neuzillet Y, Mertens L, Shariat S, Bostrom P, Mirtti T, Sagalowsky A, Ashfaq R, Broeks A, Van der Heijden M, Peters D, Curial C, De Jong J, Horenblas S, Hurst C, Tomlinson D, Knowles M, Bapat B, Jewett M, Zlotta A, Sanders J, Lotan Y, Van der Kwast T, Van Rhijn B
Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer (2014)
- European Medical Journal Urology
Syvänen K, Järveläinen H, Taimen P, Laato M, Boström PJ
Patient-derived tissue culture and xenograft models for studying prostate tumor responses to therapy (2014)
- European Journal of Cancer
Yu L, Kahkonen TE, Taimen P, Bostrom P, Tuomela J, Harkonen P